Andreas Halvorsen's TRVI Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 3.2 M shares of Trevi Therapeutics, Inc. (TRVI) worth $40.05 M, representing 0.11% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Andreas Halvorsen has maintained a strategic position in TRVI, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 3.59 M shares. Largest reduction occurred in Q4 2025, reducing 1.93 M shares.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's Trevi Therapeutics (TRVI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Trevi Therapeutics (TRVI) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1.93 M | Reduce 37.63% | 3.2 M | $12.52 |
| Q3 2025 | +3.59 M | Add 232.40% | 5.13 M | $9.15 |
| Q2 2025 | -1.68 M | Reduce 52.20% | 1.54 M | $5.47 |
| Q1 2025 | -1.17 M | Reduce 26.64% | 3.23 M | $6.29 |
| Q3 2022 | +4.4 M | New Buy | 4.4 M | $1.54 |
Andreas Halvorsen's Trevi Therapeutics Investment FAQs
Andreas Halvorsen first purchased Trevi Therapeutics, Inc. (TRVI) in Q3 2022, acquiring 4,400,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held Trevi Therapeutics, Inc. (TRVI) for 14 quarters since Q3 2022.
Andreas Halvorsen's largest addition to Trevi Therapeutics, Inc. (TRVI) was in Q3 2022, adding 4,400,000 shares worth $6.78 M.
According to the latest 13F filing for Q4 2025, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 3,198,644 shares of Trevi Therapeutics, Inc. (TRVI), valued at approximately $40.05 M.
As of the Q4 2025 filing, Trevi Therapeutics, Inc. (TRVI) represents approximately 0.11% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in Trevi Therapeutics, Inc. (TRVI) was 5,128,875 shares, as reported at the end of Q3 2025.